跳至主要内容
临床试验/IRCT20170112031893N3
IRCT20170112031893N3尚未招募3 期

Evaluate the effect of Peganum Harmala on glycemic index in diabetic patient, a triple-blind randomized, placebo controlled trial

Ghoum University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 75 years(—)
性别
All

入选标准

  • type 2 diabetes over three year
  • age group40-75
  • Distal polyneuropathy resolutions based on questionnaires Michigan
  • HBA1C8% -10%

排除标准

  • Kidney,liver,and heart failure based on the tests, history and physical exam
  • High blood pressure more than 180 mm Hg and advanced ;
  • diabetic Retinopathy
  • Pergnancy and lactation
  • History of amputation
  • the recent use of drugs for neuropathy {gabapentin , nortriptyline}
  • ?Consumers of medicines that induce delayed gastric emptying such as: Acarbose, Miglitol, Exenatid, ?benzodiazepines, calcium channel blockers, narcotics, alpha-2 adrenergic receptor agonists such as ?clonidine, tricyclic antidepressants, dopamine agonists, cholinergic muscarinic receptor antagonists, ?Octreotide, phenothiazines, cyclosporine

研究者

发起方
Ghoum University of Medical Sciences

相似试验